| Literature DB >> 15325934 |
Kenichi Tsujita1, Hideki Shimomura, Hiroaki Kawano, Jun Hokamaki, Masaya Fukuda, Takuro Yamashita, Satoru Hida, Yoshinori Nakamura, Yasuhiro Nagayoshi, Tomohiro Sakamoto, Michihiro Yoshimura, Hidekazu Arai, Hisao Ogawa.
Abstract
This clinical pilot study was a randomized, controlled, open-label study in 80 patients with acute myocardial infarction and was designed to examine the effects of a novel free radical scavenger, edaravone. Administration of edaravone before myocardial reperfusion was associated with smaller enzymatic infarcts and better clinical outcome.Entities:
Mesh：
Substances：
Year: 2004 PMID： 15325934 DOI： 10.1016/j.amjcard.2004.05.007
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778